Form 483

Essential Isotopes, LLC Form 483, 2017-11-17

FDA issued a Form 483 to Essential Isotopes, LLC on 2017-11-17 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Essential Isotopes, LLC · Columbia, United States · Issued November 17, 2017

Overview

  • 9 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Nov 2017
21 CFR 212.100(a)

Written complaint procedures

Cited by Michele L Obert

17 Nov 2017
21 CFR 212.100(a)

Written complaint procedures

Cited by Michele L Obert

17 Nov 2017
21 CFR 212.50(b)(7)

Complete instructions, procedures, specs

Cited by Michele L Obert

17 Nov 2017
21 CFR 212.50(b)(7)

Complete instructions, procedures, specs

Cited by Michele L Obert

17 Nov 2017
21 CFR 212.60(f)

Documenting procedures

Cited by Michele L Obert

Inspected site

EIEssential Isotopes, LLCColumbia, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.60(g)(3)Cited across public-safe Form 483 observations3x
21 CFR 212.100(a)Cited across public-safe Form 483 observations2x
21 CFR 212.50(b)(7)Cited across public-safe Form 483 observations2x
21 CFR 212.60(f)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 9 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere